A milestone in the company's efforts to make fertility care more affordable and accessible through simplified sperm separation.
Disclaimer: Boost Fertility is a partner of The IVF Warrior.
For many individuals and couples struggling with infertility, accessing fertility care isn't always easy. Between the cost of treatment, limited options, and the distance some patients have to travel, getting the care they need can come with significant challenges.
Making fertility care more affordable and accessible matters, and innovations that could help reduce these barriers are worth paying attention to.
November 9, 2026 — Munich, Germany — Boost Fertility announced today that the U.S. Food and Drug Administration (FDA) cleared Boost Fertility’s Pleiades Device on Friday, October 30, 2026, through the 510(k) regulatory pathway. The Pleiades Device is a matchbox-sized, single-use sperm separation device that enables sperm separation to be performed quickly and easily.
This is a critical steppingstone to bringing the Pleiades Device to market and advancing Boost Fertility’s mission to make fertility care more affordable and accessible. Daniel Wilson, CEO of Boost Fertility, says, “Affordable treatment should be available to everyone in America, and now with our FDA clearance, we can start to make that a reality.”
With only 500 fertility clinics across America, there is a significant need to expand access to fertility care. Simplifying sperm separation could help enable more healthcare professionals, including OB-GYNs and other qualified practitioners, to offer fertility services. This is particularly important in rural areas of America, where accessibility is limited to non-existent.
Boost Fertility is now inviting qualified doctors, fertility clinics and laboratories across the United States to experience the Pleiades Device firsthand.
Boost Fertility is offering five free Pleiades Devices to eligible participants in exchange for their feedback on the device’s usability.
“We’re sure that people will love our device so we are excited to give healthcare professionals the opportunity to try it out and share their feedback,” says the device inventor and Chief Scientific Officer (CSO) of Boost Fertility, Dr. Marion Vollmer.
Interested doctors, clinics and laboratories can register through Boost Fertility’s UX Evaluation Program platform to learn more and apply to participate.
Participation requires signing a Participation and Non-Disclosure Agreement. The five devices are provided strictly for evaluation purposes and must not be used for insemination or any fertility treatment.
Interested in trying the Pleiades Device?
Visit https://qrco.de/bh4Dzp to register and learn more about receiving five free devices in exchange for your feedback.
For more information:
Contact: Daniel Wilson
Tel: +49 176 6321 6345
Email: daniel@boostfertility.com
Company Website: Boostfertility.com
From The IVF Warrior
Infertility is already difficult enough without the added challenges of accessing care.
For the many individuals and couples facing these barriers, it's encouraging to see new developments focused on making fertility services more affordable and accessible. We look forward to following Boost Fertility's progress as it works toward bringing the Pleiades Device to market.
Learn more about Boost Fertility or read the original press release.
Medical Disclaimer: The information provided in this blog is intended for general informational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare provider or qualified medical professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this blog.
